Abstract
Post transplantation constrictive bronchiolitis (PTCB) is the most common pulmonary complication among long-term survivors of allogeneic hematopoietic stem cell transplantation (HSCT). It is a late manifestation of GVHD. Its treatment with high-dose systemic corticosteroids and other immunosuppressive regimens is associated with multiple side effects. Topical corticosteroids are used for the treatment of other manifestations of GVHD to minimize these side effects. We conducted a retrospective analysis of a series of adult patients to evaluate the efficacy of high-dose inhaled corticosteroids in the treatment of PTCB. Seventeen patients with new-onset airflow obstruction were diagnosed with PTCB. Their forced expiratory volume in 1 s (FEV1) declined from a median of 84% (range, 56–119) before HSCT to 53% (26–82) after HSCT. All patients received inhaled fluticasone propionate 500–940 μg two times daily. Symptoms of airway obstruction improved and FEV1 stabilized 3–6 months after treatment. We conclude that high-dose inhaled corticosteroids may be effective in the treatment of PTCB and propose a plausible mechanism of its action. A prospective evaluation of its efficacy is warranted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Milojkovic D, Mufti GJ . Extending the role of allogeneic stem-cell transplantation. Lancet 2001; 357: 652–654.
Kotloff RM, Ahya VN, Crawford SW . Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004; 170: 22–48.
Soubani AO, Miller KB, Hassoum PM . Pulmonary complications of bone marrow transplantation. Chest 1996; 109: 1066–1077.
Chien JW, Martin PJ, Gooley TA, Flowers ME, Heckbert SR, Garrett Nichols W et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2003; 168: 208–214.
Afessa B, Litzow MR, Tefferi A . Bronchiolitis obliterans and other later onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425–434.
Clark JG, Schwartz DA, Flournoy N, Sullivan KM, Crawford SW, Thomas ED . Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 107: 648–656.
Holland HK, Wingard JR, Beschorner WE, Saral R, Santos GW . Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood 1988; 72: 621–627.
Watkins TR, Chien JW, Crawford SW . Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant. Semin Respir Crit Care Med 2005; 26: 482–489.
Robinson MR, Lee SS, Rubin BI, Wayne AS, Pavletic SZ, Bishop MR et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant 2004; 33: 1031–1035.
Bertz H, Afting M, Kreisel W, Duffner U, Greinwald R, Finke J . Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD. Bone Marrow Transplant 1999; 24: 1185–1189.
American Thoracic Society. Lung function testing: selection of reference values and interpretive strategies. Am Rev Respir Dis 1991; 144: 1202–1218.
Sanchez J, Torres A, Serrano J, Roman J, Martin C, Perula L et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 20: 403–408.
Bergeron A, Belle A, Chevret S, Ribaud P, Devergie A, Esperou H et al. Combined inhaled steroids and bronchodilators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 2007; 39: 547–553.
Chien JW, Martin PJ, Flowers ME, Nichols WG, Clark JC . Implication of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 33: 759–764.
Marras TK, Chan CK, Lipton JH, Messner HA, Szalai JP, Laupacis A . Long term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant 2004; 33: 509–517.
Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP . Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28: 121–129.
Wynn TA . Fibrotic disease and the TH1/TH2 paradigm. Nat Rev Immunol 2004; 8: 583–594.
Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J et al. Pulmonary expression of IL13 causes inflammation, mucous hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779–788.
Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V et al. Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med 2001; 194: 809–821.
Georas SN, Guo J, De Fanis U, Casolaro V . T-helper cell type-2 regulation in allergic disease. Eur Respir J 2005; 26: 1119–1137.
Travis WD, Colby TV, Koss MN, Rosado-de-Christenson ML, Müller NL, King TE . Non-Neoplastic Disorders of the Lower Respiratory Tract. American registry of pathology and the armed forces institute of pathology: Washington, DC, 2002, pp 351–380.
Acknowledgements
This work was supported by a Multidisciplinary Research Program grant, MD Anderson Cancer Center: Post-Transplantation Constrictive Bronchiolitis, and a grant from the National Institutes of Health (HL072984 to BFD).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bashoura, L., Gupta, S., Jain, A. et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 41, 63–67 (2008). https://doi.org/10.1038/sj.bmt.1705877
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705877
Keywords
This article is cited by
-
Clinical features of postinfectious bronchiolitis obliterans in children undergoing long-term nebulization treatment
World Journal of Pediatrics (2018)
-
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
Respiratory Research (2016)
-
A Call to Arms: a Critical Need for Interventions to Limit Pulmonary Toxicity in the Stem Cell Transplantation Patient Population
Current Hematologic Malignancy Reports (2015)
-
Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models
Bone Marrow Transplantation (2014)
-
Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group
International Journal of Hematology (2014)